Jason Porter

Thoracic Medical Oncologist at West Cancer Center, passionate about screening/early detection, father, singer (my car is my stage), runner, views are my own

[Jason Porter @jpmd901]

@NarjustFlorezMD @AnaVManana @COlazagasti @BalazsHalmosMD @StephenVLiu @Latinamd @OncBrothers Not my monkey, not my circus… 🤷🏾‍♀️🤣🤣🤣

[Jason Porter @jpmd901]

@BalazsHalmosMD 🤣🤣🤣 I needed this laugh!

[Jason Porter @jpmd901]

Addressing disparities in lung cancer care at the 2nd Annual Lung Cancer Health Equity Summit in ATL, GA. Amazing sessions today. Now discussing artificial intelligence. It’s hardly artificial. 💁🏾‍♂️ I’m all for renaming it “assimilated intelligence!” #lscm #HealthEquity #artificalintelligence #LungCancerAwarenessMonth @EugeneManley @bjork5 @LeciaSequist @LungAwareness @west_cancer

[Dr. Luis E. Raez @LuisRaezMD]

@EugeneManley and @jpmd901 starting the II #lungcancer equity summit @DanielSumarriva #lcsm

[Jason Porter @jpmd901]

@lungoncdoc @JazzPharma @SclcSMASHERS @OncoAlert Comes as no surprise, right!?!

[Eric K. Singhi, MD @lungoncdoc]

🚨@JazzPharma announces positive results from the phase 3 IMforte study with combination lurbinectedin + atezolizumab in first-line maintenance therapy for ES-SCLC

✅ Statistically significant improvements in OS and PFS vs atezolizumab alone

@SclcSMASHERS @OncoAlert #lcsm

[Stephen V Liu, MD @StephenVLiu]

#ASTRO24 Dr. @KHigginsMD presents results from NRG LU005: a phase III study of concurrent atezolizumab with chemoradiation followed by 1y of atezo vs CRT and observation for limited stage #SCLC. Note different treatment design, different population than ADRIATIC.

[Dr Riyaz Shah @DrRiyazShah]

Lovely slide from @marinagarassino . Look at the bottom figures which beautifully document where we are in advanced NSCLC by PDL1 expression levels #ESMO24

[Jason Porter @jpmd901]

@lungoncdoc @LungAssociation @IASLC @LUNGevity @YoungLungCancer @LungCancerFaces @LungCancerRx @OncogeneCancer @lcrf_org @LiveLung1 @AmLungCSI 😍😍😍

[Jason Porter @jpmd901]

@MattSmeltzer @Latinamd 🕺🏿Let’s do it. You owe me a win after beating me before!

[Lauren Averett Byers, MD @LaurenByersMD]

POP QUIZ: Is this a waterfall plot for a new lung cancer TKI? Nope…SEZ6 ADC for Relapsed Small Cell Lung Cancer (and other NECs). #SCLC #LCSM. @MDAndersonNews Thank you to the study team and all of our investigators, patients and families. @ASCO #ASCO24

[Jennifer A. Marks, MD @jennifermarksmd]

Dr. @MattGubensMD discussing all the available treatments in 2024 for oncogenic-driven #NSCLC @ASCO #ASCO24 #lcsm

[Jason Porter @jpmd901]

@DrSteveMartin @Latinamd I’m doing it! 🤠😎🤓

[Jason Porter @jpmd901]

@gunsnrosesgirl3 🤯😍😎

[Anita Sharma @anitaklab]

@AMAZlNGNATURE Nature🌿🍃

[Matthew Smeltzer @MattSmeltzer]

Come join me and ⁦@jpmd901⁩ this Thursday for the ⁦@TotalHealthConf⁩ 2024 Diversity Dinner. There will be a lot of great content! #lcsm https://t.co/C6I0enLBOD

[Jason Porter @jpmd901]

@wisereformer @InternetH0F 🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣

[Ece Cali, MD, PhD @ececalidaylan]

Absolutely honored to be among the winners of the #TexasLung24 poster competition! ✨ Can’t wait to share our findings and foster discussions 🫁

[Chul Kim @chulkimMD]

Looking forward to discussing 'Bispecific Inhibitor and ADC in Lung Cancer' at the 20th Miami Cancer Meeting on Jan 20.

Excited to share the stage and explore challenging cases with @LuisRaezMD, @edgardo_ny, @DrSteveMartin, @jpmd901!

https://t.co/cEhvmOYkYW